Farcast Biosciences Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 28

Employees

  • Latest Deal Type
  • M&A

Farcast Biosciences General Information

Description

Developer of a human tumor micro dynamics (HTMD) platform designed to treat human tumors. The company's platform generates and mines tumor micro dynamics (TMD) response data for high-fidelity, multimodal, human-relevant translational evidence and insights that enable precision therapeutics and diagnostics development using fresh human tumors and autologous blood samples cultured in a system that preserves the tumor microenvironment in its near-native state, and simultaneous interrogation of live human tumors leads to functionally precise information that holds the key to predicting early and durable response in patients, enabling doctors to generate biosignatures based on multiple simultaneous treatment test conditions for every patient tumor.

Contact Information

Formerly Known As
Mitra Biotech, Mitra RxDx
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 40 Palafox Place
  • Suite 300
  • Pensacola, FL 32502
  • United States
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 40 Palafox Place
  • Suite 300
  • Pensacola, FL 32502
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Farcast Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-Jun-2020 Completed Generating Revenue
3. Later Stage VC (Series B) 01-Jul-2018 Completed Generating Revenue
2. Later Stage VC (Series B) 28-Aug-2016 $27.4M $29.6M Completed Generating Revenue
1. Early Stage VC (Series A) 28-Apr-2010 $2.2M $2.2M Completed Startup
To view Farcast Biosciences’s complete valuation and funding history, request access »

Farcast Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a human tumor micro dynamics (HTMD) platform designed to treat human tumors. The company's platform generat
Decision/Risk Analysis
Pensacola, FL
28 As of 2023

Waltham, MA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Farcast Biosciences Competitors (12)

One of Farcast Biosciences’s 12 competitors is BostonGene, a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BostonGene Venture Capital-Backed Waltham, MA
Biocept Formerly VC-backed San Diego, CA
Genomic Expression Venture Capital-Backed Beverly, MA
Elephas Venture Capital-Backed Madison, WI
Kiyatec Venture Capital-Backed Greenville, SC
You’re viewing 5 of 12 competitors. Get the full list »

Farcast Biosciences Patents

Farcast Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020172592-A1 A method to predict a patient's response to an anti-cancer drug from a ratio of expression levels of two sets of genes Inactive 22-Feb-2019
WO-2020172591-A1 A method to predict a patient's response to an anti-cancer drug from an expression level of a set of genes Inactive 22-Feb-2019
WO-2019164951-A1 Methods of predicting response to temporally sequenced combination therapy Inactive 22-Feb-2018
JP-2020510444-A How to predict clinical outcomes of anticancer drugs Pending 08-Feb-2017
AU-2018219831-A1 Method of predicting clinical outcome of anticancer agents Inactive 08-Feb-2017 G01N33/575
To view Farcast Biosciences’s complete patent history, request access »

Farcast Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Farcast Biosciences Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accel Venture Capital Minority
Alumni Ventures Venture Capital Minority
IKP Investment Management Venture Capital Minority
Karnataka Information Technology Venture Capital Funds Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 11 investors. Get the full list »

Farcast Biosciences FAQs

  • When was Farcast Biosciences founded?

    Farcast Biosciences was founded in 2009.

  • Where is Farcast Biosciences headquartered?

    Farcast Biosciences is headquartered in Pensacola, FL.

  • What is the size of Farcast Biosciences?

    Farcast Biosciences has 28 total employees.

  • What industry is Farcast Biosciences in?

    Farcast Biosciences’s primary industry is Decision/Risk Analysis.

  • Is Farcast Biosciences a private or public company?

    Farcast Biosciences is a Private company.

  • What is Farcast Biosciences’s current revenue?

    The current revenue for Farcast Biosciences is .

  • How much funding has Farcast Biosciences raised over time?

    Farcast Biosciences has raised $69.6M.

  • Who are Farcast Biosciences’s investors?

    Accel, Alumni Ventures, IKP Investment Management, Karnataka Information Technology Venture Capital Funds, and are 5 of 11 investors who have invested in Farcast Biosciences.

  • Who are Farcast Biosciences’s competitors?

    BostonGene, Biocept, Genomic Expression, Elephas, and Kiyatec are some of the 12 competitors of Farcast Biosciences.

  • When was Farcast Biosciences acquired?

    Farcast Biosciences was acquired on 06-Jun-2020.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process